Clinical trials query results
From Health Canada
- Medical condition:
- ANXIETY DISORDER
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- PSILOCYBIN
- Protocol title:
- A 2-PART, PHASE 2A, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF PSILOCYBIN ORAL SOLUTION IN ADULTS WITH GENERALIZED ANXIETY DISORDER
- Sponsor name:
- DIAMOND THERAPEUTICS
- Date of no objection letter:
- 2023-01-12
- Control number:
- 270675
- Trial status:
- PENDING